0001493152-26-006450
SEC filingRoadzen, Inc. (RDZN) reported Q3 2026 results for the period ending December 31, 2025, with revenue of $14.4M, up from prior periods though specific QoQ figures are not disclosed. The company posted an operating loss of -$2.4M on total costs and expenses of $16.7M, driven by high sales and marketing expenses of $7.4M and cost of services at $5.2M. Net loss attributable to ordinary shareholders was -$9.1M, or -$0 per basic and diluted share, on 78.8M weighted-average shares. Other income/expense totaled -$7.1M, including interest expense of -$3.2M offset by $5.2M fair value gains in financial instruments and $1.2M other income. Balance sheet shows total assets of $44.9M, with current assets at $34.2M including $5.1M cash. Total liabilities of $69.0M exceed equity, resulting in shareholders' deficit of -$26.6M. Cash flow from operations used -$16.5M, offset by $16.0M financing inflows, yielding a net decrease in cash of -$1.2M. High debt ($29.2M current borrowings) and negative cash flow signal liquidity pressures, while equity issuances provided support.
Roadzen, Inc. reported revenue of $14.4M for the period ending December 31, 2025, in its 10-Q filing dated February 12, 2026. Total costs and expenses were $16.7M, comprising cost of services $5.2M, research and development $294K, sales and marketing $7.4M, general and administrative $3.5M, and depreciation $312K, resulting in a loss from operations of -$2.4M. Other items included interest expense net of -$3.2M, fair value gains of $5.2M, and other income of $1.2M, for total other expense of -$7.1M. Loss before tax was -$9.5M, with income tax benefit of -$24K, yielding net loss before non-controlling interest of -$9.5M. After -$337K net loss to non-controlling interest, net loss to ordinary shareholders was -$9.1M, or -$0 per basic and diluted share on 78.8M shares. No prior period comparisons are provided in the data. Total assets stood at $44.9M against $69.0M liabilities, creating a $26.6M shareholders' deficit.
Revenue for the period was $14.4M. No segment breakdown, geographic mix, or growth drivers are disclosed in the provided XBRL data or document content. Sales and marketing expenses of $7.4M represented the largest operating expense category at 51% of total costs, suggesting focus on revenue generation efforts, but specific revenue sources or changes are not detailed.
No gross profit figure is explicitly stated, as costs and expenses aggregate lacks a distinct cost of revenue isolation beyond $5.2M cost of services. Implied gross margin on revenue of $14.4M minus $5.2M cost of services is approximately 64%, but not directly reported. Operating margin reflects loss from operations of -$2.4M on $14.4M revenue, or -16.7%. High sales and marketing ($7.4M) and G&A ($3.5M) drove expense pressure. Total costs exceeded revenue by $2.3M, with non-operating items widening the net loss to -$9.1M for shareholders. No prior period margin trends available.
Net cash used in operating activities was -$16.5M, adjusted from -$9.1M net loss by items including $312K depreciation, $380K stock compensation, $5.2M fair value changes, and working capital shifts like $5.2M prepayments recovery and $647K receivables improvement. Investing used -$713K net, mainly $826K property/intangibles purchases offset by $1.0M forward purchase proceeds. Financing generated $16.0M from $6.5M ordinary shares, $6.5M subsidiary equity to NCI, and $4.8M long-term borrowings, minus $1.9M short-term repayments. Net cash decrease was -$1.2M, with ending cash at $5.1M. Balance sheet: current liabilities $63.2M (including $18.6M short-term borrowings, $29.2M payables), non-current $5.8M, vs. $34.2M current assets. Debt totals ~$29.2M current borrowings.
No management guidance, strategic priorities, or specific risk factors are disclosed in the provided filing excerpt. Commitments referenced in note 22, but details unavailable.